BibTex RIS Cite

Can Vemurafenib Induce Vitiligo in Metastatic Melanoma Patients?

Year 2016, Volume: 33 Issue: 1, 115 - 116, 01.01.2016

Ricardo Ruiz-villaverde Daniel Sánchez-cano

Year 2016, Volume: 33 Issue: 1, 115 - 116, 01.01.2016

Ricardo Ruiz-villaverde Daniel Sánchez-cano

There are 0 citations in total.

Details

Other ID JA25ER87SF
Journal Section Editorial
Authors

Ricardo Ruiz-villaverde This is me

Daniel Sánchez-cano This is me

Publication Date January 1, 2016
Published in Issue Year 2016 Volume: 33 Issue: 1

Cite

APA Ruiz-villaverde, R., & Sánchez-cano, D. (2016). Can Vemurafenib Induce Vitiligo in Metastatic Melanoma Patients?. Balkan Medical Journal, 33(1), 115-116.
AMA Ruiz-villaverde R, Sánchez-cano D. Can Vemurafenib Induce Vitiligo in Metastatic Melanoma Patients?. Balkan Medical Journal. January 2016;33(1):115-116.
Chicago Ruiz-villaverde, Ricardo, and Daniel Sánchez-cano. “Can Vemurafenib Induce Vitiligo in Metastatic Melanoma Patients?”. Balkan Medical Journal 33, no. 1 (January 2016): 115-16.
EndNote Ruiz-villaverde R, Sánchez-cano D (January 1, 2016) Can Vemurafenib Induce Vitiligo in Metastatic Melanoma Patients?. Balkan Medical Journal 33 1 115–116.
IEEE R. Ruiz-villaverde and D. Sánchez-cano, “Can Vemurafenib Induce Vitiligo in Metastatic Melanoma Patients?”, Balkan Medical Journal, vol. 33, no. 1, pp. 115–116, 2016.
ISNAD Ruiz-villaverde, Ricardo - Sánchez-cano, Daniel. “Can Vemurafenib Induce Vitiligo in Metastatic Melanoma Patients?”. Balkan Medical Journal 33/1 (January 2016), 115-116.
JAMA Ruiz-villaverde R, Sánchez-cano D. Can Vemurafenib Induce Vitiligo in Metastatic Melanoma Patients?. Balkan Medical Journal. 2016;33:115–116.
MLA Ruiz-villaverde, Ricardo and Daniel Sánchez-cano. “Can Vemurafenib Induce Vitiligo in Metastatic Melanoma Patients?”. Balkan Medical Journal, vol. 33, no. 1, 2016, pp. 115-6.
Vancouver Ruiz-villaverde R, Sánchez-cano D. Can Vemurafenib Induce Vitiligo in Metastatic Melanoma Patients?. Balkan Medical Journal. 2016;33(1):115-6.